News

Videos allowing us to see for the first time how small circles of DNA adopt dance-like movements inside a cell have been developed by researchers at universities in Yorkshire.

A new technology developed in the Department of Chemistry can fabricate injectable biocompatible microgels, with sub-micrometre diameters, that can release bioactive agents and hence enhance stem cell growth.

Researchers have taken an important step forward in developing a controlled human infection model to test leishmaniasis vaccines.

A research technique developed at the University of York could help clinicians identify the best antibiotic to treat common conditions such as urinary tract infections.

PREV_PKDL is a €8M collaborative project funded by the European & Developing Countries Clinical Trials Partnership (EDCTP2) Programme supported by the European Union. The project is the joint effort of leading European and African experts with proven track records in research and development of products against leishmaniasis.

Researchers at York are to collaborate with a leading specialist in the field of deubiquitylase (DUB) enzymes in the fight against Leishmaniasis disease. DUBs are part of an essential protein degradation pathway in cells that use a process called ubiquitination.

The Biomaterials and Tissue Engineering Group (BiTEG) 22nd annual meeting was hosted by the University of Leeds as an online event on Thursday 17 December 2020.

Researchers from the Universities of York and Melbourne have shed new light on how viruses like hepatitis B, dengue and SARS-CoV-2 hijack a cell paving the way for potential anti-viral drugs to stop the virus in its tracks.

The Department of Biology's Dr Katherine Bridge has just been awarded the Kay Kendall Leukaemia Fund Intermediate Fellowship for her research, one of only two recipients this year.

A team of scientists - including an academic from the University of York - has been awarded more than £8m (9.1m euros) for a major research programme into how enzymes work on complex sugars.

Pioneering research at the University of York could help us understand how the latest new antibiotics against tuberculosis (TB) work - and pave the way for improved treatments in the future.

A drug used to treat cirrhosis of the liver may be an effective treatment for a form of Dementia and motorneuron disease, scientists have discovered.

Researchers at York are to explore new advances in human blood stem cell research with partners in Japan and Cambridge.

UK Scientists are launching a major new project to answer key questions on how the immune system interacts with COVID-19, in order to develop better treatments, diagnostics and vaccines.

Scientists say they are a step closer to developing a drug to kill the trypanosome parasite that causes human African trypanosomiasis, otherwise known as sleeping sickness, paving the way for a potential cure.

Researchers are using laser-light technology to develop handheld biosensors with the potential to deliver fast, real-time blood test results for patients including those suffering from COVID-19 with secondary infections such as pneumonia.

Researchers at York have discovered a new mechanism which is used by cells of the immune system to control the strength of our response to infections.

Research from the Department of Chemistry in York is providing vital insights into the novel Coronavirus SARS-CoV-2, and may help underpin antibody tests and future therapies.

A team from the University of York have produced a protein which stores and protects the genome of the SARS-CoV-2 virus, which causes COVID-19, paving the way to possible antiviral therapies.

A piece of high-tech equipment used for the diagnosis of COVID-19 has been loaned to York Hospital by the University of York.

Steve Johnson is co-investigator on a new BBSRC (Biotechnology and Biological Sciences Research Council) Tools and Technology grant.

New research has deciphered how rogue communications in blood stem cells can cause Leukaemia.

York hosted the 21st annual 'Work in Progress Meeting' of the White Rose Biomaterials and Tissue Engineering Group on 16 December.

Dr Lianne Willems, who is part of the Molecular and Cellular Medicine theme, has been awarded a five-year research grant worth €1.5m to support the first phase of her career as an independent academic here in York.

Dr Steven Quinn, who is part of the Neuroscience theme, has been awarded the research fellowship.

A new £2.3m three-year Newton project will be led by Professor Jeremy Mottram, Director of York Biomedical Research Institute (YBRI), and Professor Angela Cruz of the Ribeirão Preto Medical School.

The first three York Biomedical Research Institute social events were themed around Immunology, Haematology and Infection (24 January 2019), Neuroscience (28 February 2019) and Molecular and Cellular Medicine (28 March 2019).

Researchers across the University, including Dr Yvette Hancock have been awarded fellowships to help translate their work into potential business ideas.

Researchers from York Biomedical Research Institute (YBRI) have recently been published.

Molecular and Cellular Medicine researcher Professor Jane Thomas-Oates has been named the British Mass Spectrometry Society Lecturer for 2019.

Gulab Rani, a PhD student working under the Immunology, Haematology and Infection theme, has been selected as a winner of the worldwide Vector Labs 2018 image competition.

York Biomedical Research Institute (YBRI) officially launched on Tuesday 4 December 2018 by highlighting some of the excellent biomedical research happening at York to an audience of over 120.

Professor Jeremy Mottram (Chair in Pathogen Biology, Department of Biology) has been appointed as Founding Director of the York Biomedical Research Institute (YBRI) from 1 May 2018.